ARM's CEO doubled the AGI CPU demand pipeline to $2 billion, but at 127x forward earnings, the stock earns a HOLD at $284.95. NVIDIA trades at just 25x forward earnings with 85% revenue growth, making ARM's 127x multiple nearly impossible to justify on fundamentals alone. The bull case reaches $428 on AGI CPU revenue milestones, while an adverse Qualcomm ruling could drag ARM toward $226.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Arm didn't make the cut. Grab the names FREE today. Arm Holdings (NASDAQ:ARM) story is straightforward: a licensing business is turning into a data center silicon business.
On the fiscal Q1 2027 call, CEO Rene Haas doubled the customer demand pipeline for the Arm AGI CPU to more than $2 billion across FY2027 and FY2028, up from the $1 billion opportunity flagged a quarter earlier. That is the AI signal driving this call. Our 24/7 Wall St. price target for Arm is $284.95, pointing to modest upside from the current $271.43 price.
That is a hold at 90% confidence. Arm is executing, but valuation already discounts much of the story. Arm has had a volatile 2026.
Shares are up 148.31% year to date after starting at $109.31, peaked in June at $412.55, then gave back roughly a third of that move. The most recent quarter reinforced the two-track story: revenue of $1.289 billion grew 22.4% and beat consensus, while GAAP EPS of $0.25 missed the $0.40 consensus estimate as R&D climbed to $838 million. Data center royalties again more than doubled year over year.
The bull case gets Arm to $428.74 in twelve months, a 57.96% total return. The mechanics: AGI CPU shipments crossing 10% of revenue, first-generation gross margins landing in the high 30% to low 40% range with a path to 50%, and continued royalty ramp from NVIDIA's Vera, Google's Axion, AWS Graviton 5, and Microsoft Cobalt. Haas told investors that "AI is changing where and how compute happens, and Arm is at the center of it," and pointed to a data center CPU TAM that peers now peg up to $200 billion.
Extract — continue reading at the source.
